Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstitut Paoli-Calmettes
About this trial
Cohort of subjects carrying a BRCA gene mutation: genetic predispositions to breast and ovarian cancers
Eligibility criteria
Qualifiers
Woman or man, with or without cancer, carrying a deleterious BRCA1/BRCA2 mutation, aged 18 years and over.
Woman with or without breast cancer or ovarian cancer at baseline.
Man with or without breast cancer at baseline.
Signed consent to participation
Disqualifiers
A person of legal age subject to a legal protection measure, or unable to express consent.
Impossibility to submit to the follow-up of the test for geographical, social or psychological reasons
Trial design
Treatments tested in this trial
- Questionnaires
Treatment groups
5,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Institut Paoli-Calmettes
Lead sponsor
UNICANCER - Le Groupe génétique et cancer (GGC)
Collaborator
Source ClinicalTrials.gov